Skip to main content

diabetic nephropathy Archives

Clue to diabetic kidney disease

Oct. 5, 2020—Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication.

Read more


Targeting diabetic kidney disease

Oct. 12, 2018—Pathways activated by the epidermal growth factor receptor may be attractive targets to treat diabetic kidney disease, according to new findings from Vanderbilt investigators.

Read more


New tools to combat kidney fibrosis

Oct. 13, 2017—Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.

Read more


NIH grant spurs diabetic nephropathy research

Oct. 30, 2014—Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy.

Read more


Burroughs Wellcome Fund lauds Bhave’s research

Aug. 22, 2013—Gautam Bhave, M.D., Ph.D., assistant professor of Medicine, is receiving the Burroughs Wellcome Fund 2013 Career Award for Medical Scientists (CAMS) for his research on the role of peridoxasin and protein halogenation in diabetic nephropathy.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more